EVMN compared with OCS: revenue, margins and what each company keeps, and the suppliers and customers both name

EVMNEvommune, Inc.

Mkt capRevenueRevenue

OCSOculis Holding AG

Mkt capRevenueRevenue

Compare

EVMNEvommune, Inc.

OCSOculis Holding AG

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

EVMN

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+5.23%—

May 8 '26±38.2%▲+1.87%×0.05

Q1 FY26—▲+5.62%—

Q3 FY25—▼−8.53%—

OCS

No earnings history for OCS.

= impliedEVMN realized, solidOCS realized, hatchedOne scale, both sides: full bar = 39%× = |realized| ÷ impliedSource: market data

EVMNEvommune, Inc.

6.72· pre 6.72· delayed

Mkt cap$243.2MRevenue$10MQ3 FY25

OCSOculis Holding AG

8.28· pre 8.28· delayed

Pre-marketOct 30 '26delayed

Mkt cap$496.3MRevenue—

Compare

Pre-marketOct 30 '26delayed

EVMNEvommune, Inc.

OCSOculis Holding AG

6.72pre 6.72delayed

Price

8.28pre 8.28delayed

$243.2M

Mkt cap

$496.3M

Q3 FY25$10M

Revenue

—

EVMN6.72vsOCS8.28Pre-marketOct 30 '26delayed